Sagol O - Search Results

1

Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis.

Aysal A, Agalar C, Egeli T, Unek T, Oztop I, Obuz F, Sagol O. Aysal A, et al. Among authors: sagol o. Endocr Pathol. 2021 Dec;32(4):461-472. doi: 10.1007/s12022-021-09687-w. Epub 2021 Jul 20. Endocr Pathol. 2021. PMID: 34283399

2

Immunohistochemical detection of pS2 protein and heat shock protein-70 in pancreatic adenocarcinomas. Relationship with disease extent and patient survival.

Sagol O, Tuna B, Coker A, Karademir S, Obuz F, Astarcioglu H, Küpelioglu A, Astarcioglu I, Topalak O. Sagol O, et al. Pathol Res Pract. 2002;198(2):77-84. doi: 10.1078/0344-0338-00190. Pathol Res Pract. 2002. PMID: 11928868

3

Prognostic significance of mean nuclear volume in pancreatic adenocarcinoma.

Ozkal S, Sagol O, Karademir S, Coker A, Astarcioglu H, Küpelioglu A, Astarcioglu I, Topalak O, Göktay Y. Ozkal S, et al. Among authors: sagol o. Anal Quant Cytol Histol. 2003 Aug;25(4):221-6. Anal Quant Cytol Histol. 2003. PMID: 12961829

4

Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma.

Sis B, Sağol O, Küpelioğlu A, Sokmen S, Terzi C, Fuzun M, Ozer E, Bishop P. Sis B, et al. Among authors: sagol o. Pathol Res Pract. 2004;200(5):379-87. doi: 10.1016/j.prp.2004.02.012. Pathol Res Pract. 2004. PMID: 15239346

5

The importance of cyclin D1 and Ki67 expression on the biological behavior of pancreatic adenocarcinomas.

Lebe B, Sağol O, Ulukuş C, Coker A, Karademir S, Astarcioglu H, Küpelioğlu A, Astarcioğlu I, Obuz F. Lebe B, et al. Among authors: sagol o. Pathol Res Pract. 2004;200(5):389-96. doi: 10.1016/j.prp.2004.02.010. Pathol Res Pract. 2004. PMID: 15239347

6

Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.

Oztop I, Yilmaz U, Yavuzsen T, Yaren A, Tarhan O, Sagol O, Coker A, Alakavuklar M. Oztop I, et al. Among authors: sagol o. Chemotherapy. 2004 Jun;50(3):127-32. doi: 10.1159/000077886. Chemotherapy. 2004. PMID: 15282439 Clinical Trial.

7

Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics.

Culhaci N, Sagol O, Karademir S, Astarcioglu H, Astarcioglu I, Soyturk M, Oztop I, Obuz F. Culhaci N, et al. Among authors: sagol o. BMC Cancer. 2005 Aug 8;5:98. doi: 10.1186/1471-2407-5-98. BMC Cancer. 2005. PMID: 16086840 Free PMC article.

8

Is rectal washout necessary in anterior resection for rectal cancer? A prospective clinical study.

Terzi C, Unek T, Sağol O, Yilmaz T, Füzün M, Sökmen S, Ergör G, Küpelioğlu A. Terzi C, et al. Among authors: sagol o. World J Surg. 2006 Feb;30(2):233-41. doi: 10.1007/s00268-005-0300-x. World J Surg. 2006. PMID: 16425079 Clinical Trial.

9

Efficiency of MR imaging in the detection of malignant liver lesions.

Obuz F, Oksüzler M, Seçil M, Sağol O, Karademir S, Astarcioğlu H. Obuz F, et al. Among authors: sagol o. Diagn Interv Radiol. 2006 Mar;12(1):17-21. Diagn Interv Radiol. 2006. PMID: 16538579

10

The role of SPIO-enhanced MRI in the detection of malignant liver lesions.

Savranoglu P, Obuz F, Karasu S, Coker A, Secil M, Sagol O, Igci E, Dicle O, Astarcioglu I. Savranoglu P, et al. Among authors: sagol o. Clin Imaging. 2006 Nov-Dec;30(6):377-81. doi: 10.1016/j.clinimag.2006.06.001. Clin Imaging. 2006. PMID: 17101405 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters